Literature DB >> 15058592

Therapeutic drug monitoring for sirolimus in whole blood of organ transplants by high-performance liquid chromatography with ultraviolet detection.

Miguel Angel Campanero1, Ernesto Cardenas, Belén Sádaba, Emilio García-Quetglas, Maria Jose Muñoz-Juarez, Isabel Gil-Aldea, David Pazo, Jose Ramón Azanza, Jesús Honorato.   

Abstract

We developed and validated an accurate, sensitive, precise and rapid HPLC method with UV detection for the determination of sirolimus in blood samples from renal, cardiac and hepatic transplants. This method overcomes most of the problems related to previously published assays using a narrow-bore column with base deactivated C18 reversed phase. Whole blood samples were purified by a combination of a precipitating blood matrix with zinc sulphate and a single step liquid-liquid extraction with acetone and 1-chlorobutane. Calibration curves (range 2.5-150 ng/ml), were linear with coefficients of correlation better than 0.996. The relative standard deviation was determined to be less than 8%. The present method has also been validated by a reference laboratory (St. George's Hospital Medical School, London, UK). More of 300 clinical samples have been analysed with this method.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15058592     DOI: 10.1016/j.chroma.2003.10.121

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  4 in total

1.  The effects of lyophilization on the physico-chemical stability of sirolimus liposomes.

Authors:  Saeed Ghanbarzadeh; Hadi Valizadeh; Parvin Zakeri-Milani
Journal:  Adv Pharm Bull       Date:  2013-02-07

2.  A reversed phase high performance liquid chromatographic method for determination of rapamycin.

Authors:  Hamideh Sobhani; Alireza Shafaati; Nastaran Nafissi-Varcheh; Reza Aboofazeli
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

3.  Steady Augmentation of Anti-Osteoarthritic Actions of Rapamycin by Liposome-Encapsulation in Collaboration with Low-Intensity Pulsed Ultrasound.

Authors:  Chung-Hwan Chen; Shyh Ming Kuo; Yin-Chun Tien; Po-Chih Shen; Yi-Wen Kuo; Han Hsiang Huang
Journal:  Int J Nanomedicine       Date:  2020-05-28

4.  Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed.

Authors:  Guillaume Le Guyader; Bernard Do; Victoire Vieillard; Karine Andrieux; Muriel Paul
Journal:  Pharmaceutics       Date:  2020-11-07       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.